Cargando…
Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
Autor principal: | Frontiers Production Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027792/ https://www.ncbi.nlm.nih.gov/pubmed/36959854 http://dx.doi.org/10.3389/fphar.2023.1173490 |
Ejemplares similares
-
Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
por: Boudou, Cédric, et al.
Publicado: (2022) -
Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023) -
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Lactobacillus plantarum RS-09 Induces M1-Type Macrophage Immunity Against Salmonella typhimurium Challenge via the TLR2/NF-κB Signalling Pathway
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Discovery and Preclinical Development of Orally Active Small Molecules That Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism
por: Frontiers Production Office,
Publicado: (2021)